{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:35:11Z","timestamp":1793907311711,"version":"4.8.0"},"reference-count":92,"publisher":"Oxford University Press (OUP)","issue":"9","funder":[{"name":"Astellas Pharma, Gilead Sciences, Merck, and Pfizer"},{"name":"Basilea, Gilead Sciences, Merck, and Pfizer"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9,1]]},"abstract":"<jats:p>The risk of patients with ALL and recipients of an allogeneic HSCT developing Pneumocystis jirovecii pneumonia is sufficiently high to warrant guidelines for the laboratory diagnosis, prevention and treatment of the disease. In this issue, the European Conference on Infections in Leukemia (ECIL) presents its recommendations in three companion papers.<\/jats:p>","DOI":"10.1093\/jac\/dkw155","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T09:07:38Z","timestamp":1471856858000},"page":"2379-2385","source":"Crossref","is-referenced-by-count":118,"title":["Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients"],"prefix":"10.1093","volume":"71","author":[{"given":"Catherine","family":"Cordonnier","sequence":"first","affiliation":[{"name":"Department of Haematology, Henri Mondor Teaching Hospital, Assistance Publique-h\u00f4pitaux de Paris, and Universit\u00e9 Paris-Est-Cr\u00e9teil, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Cesaro","sequence":"additional","affiliation":[{"name":"Department of Haematology, Oncoematologia Pediatrica, Policlinico G. B. Rossi, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Maschmeyer","sequence":"additional","affiliation":[{"name":"Department of Haematology, Oncology and Palliative Care, Ernst-von-Bergmann Klinikum, Potsdam, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Einsele","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Julius Maximilians University, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Peter","family":"Donnelly","sequence":"additional","affiliation":[{"name":"Department of Haematology Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Alanio","sequence":"additional","affiliation":[{"name":"Parasitology-Mycology Laboratory, Groupe Hospitalier Lariboisi\u00e8re Saint-Louis Fernand Widal, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Universit\u00e9 Paris-Diderot, Sorbonne Paris Cit\u00e9, and Institut Pasteur, Unit\u00e9 de Mycologie Mol\u00e9culaire, CNRS URA3012, Centre National de R\u00e9f\u00e9rence Mycoses Invasives et Antifongiques, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe M.","family":"Hauser","sequence":"additional","affiliation":[{"name":"Institute of Microbiology, Lausanne University Hospital and University, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Lagrou","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, KU Leuven \u2013 University of Leuven, Leuven, Belgium and National Reference Center for Mycosis, Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem J. G.","family":"Melchers","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannik","family":"Helweg-Larsen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Matos","sequence":"additional","affiliation":[{"name":"Medical Parasitology Unit, Group of Opportunistic Protozoa\/HIV and Other Protozoa, Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Bretagne","sequence":"additional","affiliation":[{"name":"Parasitology-Mycology Laboratory, Groupe Hospitalier Lariboisi\u00e8re Saint-Louis Fernand Widal, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Universit\u00e9 Paris-Diderot, Sorbonne Paris Cit\u00e9, and Institut Pasteur, Unit\u00e9 de Mycologie Mol\u00e9culaire, CNRS URA3012, Centre National de R\u00e9f\u00e9rence Mycoses Invasives et Antifongiques, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[{"name":"Department of Haematology, Acute Leukaemia and Stem Cell Transplantation Unit, University Hospitals Leuven, Campus Gasthuisberg, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,5,12]]},"reference":[{"key":"2019092716314184600_DKW155C1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0022-3476(73)80113-1","article-title":"Pneumocystis carinii pneumonitis in children with malignancies","volume":"82","author":"Hughes","year":"1973","journal-title":"J Pediatr"},{"key":"2019092716314184600_DKW155C2","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"key":"2019092716314184600_DKW155C3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/334519a0","article-title":"Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi","volume":"334","author":"Edman","year":"1988","journal-title":"Nature"},{"key":"2019092716314184600_DKW155C4","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/jac\/dkw156","article-title":"ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Alanio","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2019092716314184600_DKW155C5","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/jac\/dkw157","article-title":"ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Maertens","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2019092716314184600_DKW155C6","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/jac\/dkw158","article-title":"ECIL guidelines for the treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients","volume":"71","author":"Maschmeyer","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2019092716314184600_DKW155C7","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/cncr.2820360912","article-title":"Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis","volume":"36","author":"Hughes","year":"1975","journal-title":"Cancer"},{"key":"2019092716314184600_DKW155C8","first-page":"28","article-title":"Pneumonia during therapy for childhood acute lymphoblastic leukemia","volume":"134","author":"Siegel","year":"1980","journal-title":"Am J Dis Child"},{"key":"2019092716314184600_DKW155C9","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/clinids\/4.6.1119","article-title":"Nonbacterial pneumonia after allogeneic bone marrow transplantation","volume":"4","author":"Meyers","year":"1982","journal-title":"Rev Infect Dis"},{"key":"2019092716314184600_DKW155C10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jpeds.2013.10.021","article-title":"Single-day trimethoprim\/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with cancer","volume":"164","author":"Caselli","year":"2014","journal-title":"J Pediatr"},{"key":"2019092716314184600_DKW155C11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jiac.2013.09.004","article-title":"Pneumocystis polymerase chain reaction and blood (1\u21923)-\u03b2-d-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia","volume":"20","author":"Matsumura","year":"2013","journal-title":"J Infect Chemother"},{"key":"2019092716314184600_DKW155C12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1399-3062.2012.00739.x","article-title":"Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons","volume":"14","author":"McKinnell","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"2019092716314184600_DKW155C13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2141.2002.03419.x","article-title":"Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres","volume":"117","author":"Pagano","year":"2002","journal-title":"Br J Haematol"},{"key":"2019092716314184600_DKW155C14","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1086\/342338","article-title":"Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study","volume":"35","author":"Zahar","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2019092716314184600_DKW155C15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3201\/eid1903.121151","article-title":"Increasing Pneumocystis pneumonia, England, UK, 2000\u20132010","volume":"19","author":"Maini","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"2019092716314184600_DKW155C16","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/00365540410021180","article-title":"Risk factors analysis for Pneumocystis jiroveci pneumonia (PCP) in patients with haematological malignancies and pneumonia","volume":"36","author":"Roblot","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"2019092716314184600_DKW155C17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/00365548.2013.865142","article-title":"Pneumocystis jirovecii pneumonia in HIV-negative patients: a prospective study with focus on immunosuppressive drugs and markers of immune impairment","volume":"46","author":"Roblot","year":"2014","journal-title":"Scand J Infect Dis"},{"key":"2019092716314184600_DKW155C18","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1365-2362.2009.02206.x","article-title":"Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily","volume":"39","author":"Sillaber","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"2019092716314184600_DKW155C19","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJM199105093241901","article-title":"Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group","volume":"324","author":"Frickhofen","year":"1991","journal-title":"N Engl J Med"},{"key":"2019092716314184600_DKW155C20","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1182\/blood-2012-02-407684","article-title":"Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party","volume":"119","author":"Marsh","year":"2012","journal-title":"Blood"},{"key":"2019092716314184600_DKW155C21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJMoa1103975","article-title":"Horse versus rabbit antithymocyte globulin in acquired aplastic anemia","volume":"365","author":"Scheinberg","year":"2011","journal-title":"N Engl J Med"},{"key":"2019092716314184600_DKW155C22","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3324\/haematol.2012.063420","article-title":"Infections in myelodysplastic syndromes","volume":"97","author":"Toma","year":"2012","journal-title":"Haematologica"},{"key":"2019092716314184600_DKW155C23","first-page":"651","article-title":"Pneumocystis carinii pneumonia in patients with solid tumors and lymphomas: predisposing factors and outcome","volume":"25","author":"Barbounis","year":"2005","journal-title":"Anticancer Res"},{"key":"2019092716314184600_DKW155C24","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00277-011-1268-2","article-title":"Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma","volume":"90","author":"Huang","year":"2011","journal-title":"Ann Hematol"},{"key":"2019092716314184600_DKW155C25","first-page":"663","article-title":"Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies","volume":"100","author":"Kovacs","year":"1984","journal-title":"Medicine"},{"key":"2019092716314184600_DKW155C26","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10096-006-0149-4","article-title":"Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients","volume":"25","author":"Torres","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2019092716314184600_DKW155C27","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1378\/chest.118.3.704","article-title":"Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995. Comparison of HIV-associated cases to other immunocompromised states","volume":"118","author":"Mansharamani","year":"2000","journal-title":"Chest"},{"key":"2019092716314184600_DKW155C28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pneumo.2011.06.001","article-title":"Pneumocystose pulmonaire chez des patients immunod\u00e9prim\u00e9s non infect\u00e9s par le VIH: \u00e9tude de 41 cas","volume":"67","author":"Toper","year":"2011","journal-title":"Rev Pneumol Clin"},{"key":"2019092716314184600_DKW155C29","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1128\/IAI.00136-13","article-title":"Dectin immunoadhesins and Pneumocystis pneumonia","volume":"81","author":"Ricks","year":"2013","journal-title":"Infect Immun"},{"key":"2019092716314184600_DKW155C30","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/QAD.0b013e32835e2c90","article-title":"Lower incidence of Pneumocystis jirovecii pneumonia among Africans in the Netherlands host or environmental factors?","volume":"27","author":"Schoffelen","year":"2013","journal-title":"AIDS"},{"key":"2019092716314184600_DKW155C31","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1378\/chest.12-0477","article-title":"Pneumocystis pneumonia in patients treated with rituximab","volume":"144","author":"Martin-Garrido","year":"2013","journal-title":"Chest"},{"key":"2019092716314184600_DKW155C32","doi-asserted-by":"crossref","first-page":"S416","DOI":"10.1093\/clinids\/17.Supplement_2.S416","article-title":"Pneumocystis carinii pneumonia in patients without AIDS","volume":"17","author":"Sepkowitz","year":"1993","journal-title":"Clin Infect Dis"},{"key":"2019092716314184600_DKW155C33","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jama.1992.03480060078034","article-title":"Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital","volume":"267","author":"Sepkowitz","year":"1992","journal-title":"JAMA"},{"key":"2019092716314184600_DKW155C34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illnesses and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"2019092716314184600_DKW155C35","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1164\/ajrccm\/140.5.1204","article-title":"Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS","volume":"140","author":"Limper","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"2019092716314184600_DKW155C36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1086\/514542","article-title":"Pneumocystis carinii pneumonia in patients receiving chemotherapy for breast cancer","volume":"25","author":"Kulke","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2019092716314184600_DKW155C37","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1378\/chest.103.6.1923a","article-title":"Pneumocystis carinii pneumonia and methotrexate therapy","volume":"103","author":"Kane","year":"1993","journal-title":"Chest"},{"key":"2019092716314184600_DKW155C38","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/thx.46.12.936","article-title":"Pneumocystis carinii pneumonia as a complication of methotrexate treatment of asthma","volume":"46","author":"Kuitert","year":"1991","journal-title":"Thorax"},{"key":"2019092716314184600_DKW155C39","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood.V82.6.1695.1695","article-title":"Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment","volume":"82","author":"O'Brien","year":"1993","journal-title":"Blood"},{"key":"2019092716314184600_DKW155C40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ajh.2830490207","article-title":"Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies: a role for Pneumocystis carinii pneumonia prophylaxis","volume":"49","author":"Byrd","year":"1995","journal-title":"Am J Hematol"},{"key":"2019092716314184600_DKW155C41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cncr.21151","article-title":"Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen","volume":"104","author":"Tsimberidou","year":"2005","journal-title":"Cancer"},{"key":"2019092716314184600_DKW155C42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clml.2011.07.006","article-title":"Risk factors for Pneumocystis jirovecii pneumonia in patients with lymphoproliferative disorders","volume":"12","author":"Obeid","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2019092716314184600_DKW155C43","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/pbc.21287","article-title":"Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients","volume":"50","author":"Kim","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"2019092716314184600_DKW155C44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3324\/haematol.10564","article-title":"Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen","volume":"92","author":"Kolstad","year":"2007","journal-title":"Haematologica"},{"key":"2019092716314184600_DKW155C45","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3109\/10428191003699860","article-title":"High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone","volume":"51","author":"Kamel","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"2019092716314184600_DKW155C46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/ejh.12135","article-title":"Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis","volume":"91","author":"Haeusler","year":"2013","journal-title":"Eur J Haematol"},{"key":"2019092716314184600_DKW155C47","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1200\/JCO.2002.06.119","article-title":"Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine","volume":"20","author":"Rai","year":"2002","journal-title":"J Clin Oncol"},{"key":"2019092716314184600_DKW155C48","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1200\/JCO.2007.12.9098","article-title":"Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia","volume":"25","author":"Hillmen","year":"2007","journal-title":"J Clin Oncol"},{"key":"2019092716314184600_DKW155C49","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1038\/sj.leu.2404435","article-title":"Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation","volume":"20","author":"Karlsson","year":"2006","journal-title":"Leukemia"},{"key":"2019092716314184600_DKW155C50","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1182\/blood.V99.10.3554","article-title":"Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study","volume":"99","author":"Keating","year":"2002","journal-title":"Blood"},{"key":"2019092716314184600_DKW155C51","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1200\/JCO.2010.29.7978","article-title":"Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101","volume":"28","author":"Lin","year":"2010","journal-title":"J Clin Oncol"},{"key":"2019092716314184600_DKW155C52","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1182\/blood-2002-01-0159","article-title":"Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)","volume":"100","author":"Lundin","year":"2002","journal-title":"Blood"},{"key":"2019092716314184600_DKW155C53","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/504811","article-title":"Infectious complications associated with alemtuzumab use for lymphoproliferative disorders","volume":"43","author":"Martin","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2019092716314184600_DKW155C54","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.leu.2403354","article-title":"Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)","volume":"18","author":"Wendtner","year":"2004","journal-title":"Leukemia"},{"key":"2019092716314184600_DKW155C55","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3109\/10428194.2012.659735","article-title":"Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group","volume":"53","author":"Kim","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"2019092716314184600_DKW155C56","first-page":"1283","article-title":"The value of Pneumocystis carinii antibody and antigen detection for diagnosis of Pneumocystis carinii pneumonia after marrow transplantation","volume":"120","author":"Meyers","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"2019092716314184600_DKW155C57","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.bmt.1704162","article-title":"Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation","volume":"32","author":"Chen","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"2019092716314184600_DKW155C58","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.bmt.1705149","article-title":"Occurrence of Pneumocystis jirovecii after allogeneic stem cell transplantation: a 6-year retrospective study","volume":"36","author":"De Castro","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"2019092716314184600_DKW155C59","first-page":"267","article-title":"Pneumocystis carinii pneumonitis following bone marrow transplantation","volume":"10","author":"Tuan","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"2019092716314184600_DKW155C60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1083-8791(00)70050-4","article-title":"Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections","volume":"6","author":"Vasconcelles","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"2019092716314184600_DKW155C61","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/sj.bmt.1702004","article-title":"A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim\/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation","volume":"24","author":"Colby","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"2019092716314184600_DKW155C62","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1399-3062.2008.00321.x","article-title":"No occurrence of Pneumocystis jiroveci (carinii) pneumonia in 120 adults undergoing myeloablative unrelated cord blood transplantation","volume":"10","author":"Tomonari","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"2019092716314184600_DKW155C63","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1086\/313509","article-title":"High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis","volume":"29","author":"Souza","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2019092716314184600_DKW155C64","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/sj.bmt.1705856","article-title":"Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation","volume":"40","author":"Bjorklund","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"2019092716314184600_DKW155C65","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2019092716314184600_DKW155C66","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.prrv.2009.06.010","article-title":"Pneumocystis pneumonia in children","volume":"10","author":"Pyrgos","year":"2009","journal-title":"Paediatr Respir Rev"},{"key":"2019092716314184600_DKW155C67","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/ppul.21577","article-title":"Clinical conditions associated with PCP in children","volume":"47","author":"Saltzman","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"2019092716314184600_DKW155C68","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1542\/peds.2006-1360","article-title":"Successful intermittent prophylaxis with trimethoprim\/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients","volume":"120","author":"Lindemulder","year":"2007","journal-title":"Pediatrics"},{"key":"2019092716314184600_DKW155C69","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1128\/CMR.10.3.401","article-title":"Extrapulmonary pneumocystosis","volume":"10","author":"Ng","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"2019092716314184600_DKW155C70","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s10156-012-0408-5","article-title":"Analysis of clinical features of non-HIV Pneumocystis jirovecii pneumonia","volume":"18","author":"Ainoda","year":"2012","journal-title":"J Infect Chemother"},{"key":"2019092716314184600_DKW155C71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc6806","article-title":"Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection","volume":"12","author":"Monnet","year":"2008","journal-title":"Critical Care"},{"key":"2019092716314184600_DKW155C72","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1259\/bjr\/39696316","article-title":"Differences and similarities of cytomegalovirus and pneumocystis pneumonia in HIV-negative immunocompromised patients\u2014thin section CT morphology in the early phase of the disease","volume":"80","author":"Vogel","year":"2007","journal-title":"Br J Radiol"},{"key":"2019092716314184600_DKW155C73","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1001\/archneur.1991.00530160074017","article-title":"Pneumocystis carinii pneumonia in patients with primary brain tumors","volume":"84","author":"Henson","year":"1991","journal-title":"Arch Neurol"},{"key":"2019092716314184600_DKW155C74","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00043426-200206000-00018","article-title":"Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids","volume":"24","author":"Huh","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"2019092716314184600_DKW155C75","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF02113579","article-title":"Pneumocystis carinii pneumonia in HIV-negative patients with haematologic disease","volume":"25","author":"van der Lelie","year":"1997","journal-title":"Infection"},{"key":"2019092716314184600_DKW155C76","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/mpo.1157","article-title":"Pneumocystis carinii pneumonia during maintenance treatment of childhood acute lymphoblastic leukemia","volume":"37","author":"Poulsen","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"2019092716314184600_DKW155C77","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10156-012-0453-0","article-title":"Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies","volume":"18","author":"Tasaka","year":"2012","journal-title":"J Infect Chemother"},{"key":"2019092716314184600_DKW155C78","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00408-009-9214-y","article-title":"Radiological features of Pneumocystis jirovecii pneumonia in immunocompromised patients with and without AIDS","volume":"188","author":"Hardak","year":"2010","journal-title":"Lung"},{"key":"2019092716314184600_DKW155C79","first-page":"w13184","article-title":"Accuracy of serum LDH elevation for the diagnosis of Pneumocystis jiroveci pneumonia","volume":"141","author":"Vogel","year":"2011","journal-title":"Swiss Med Wkly"},{"key":"2019092716314184600_DKW155C80","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1183\/09031936.95.08091548","article-title":"Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressed patients","volume":"8","author":"Ewig","year":"1995","journal-title":"Eur Respir J"},{"key":"2019092716314184600_DKW155C81","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10096-012-1730-7","article-title":"Human herpes virus co-infection is associated with mortality in HIV-negative patients with Pneumocystis jirovecii pneumonia","volume":"32","author":"Fillatre","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2019092716314184600_DKW155C82","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00277-009-0888-2","article-title":"Pneumocystis jiroveci pneumonia detected by FDG-PET","volume":"89","author":"Nakazato","year":"2010","journal-title":"Ann Hematol"},{"key":"2019092716314184600_DKW155C83","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1378\/chest.07-0223","article-title":"Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients","volume":"132","author":"Bollee","year":"2007","journal-title":"Chest"},{"key":"2019092716314184600_DKW155C84","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2214\/ajr.172.5.10227507","article-title":"The changing face of Pneumocystis carinii pneumonia in AIDS patients","volume":"172","author":"Boiselle","year":"1999","journal-title":"Am J Roentgenol"},{"key":"2019092716314184600_DKW155C85","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2214\/ajr.161.3.8352098","article-title":"Lung cysts associated with Pneumocystis carinii pneumonia: radiographic characteristics, natural history, and complications","volume":"161","author":"Chow","year":"1993","journal-title":"AJR"},{"key":"2019092716314184600_DKW155C86","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2169\/internalmedicine.49.2871","article-title":"Comparison of clinical and radiological features of Pneumocystis pneumonia between malignancy cases and acquired immunodeficiency syndrome cases: a multicenter study","volume":"49","author":"Tasaka","year":"2010","journal-title":"Intern Med"},{"key":"2019092716314184600_DKW155C87","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00408-012-9392-x","article-title":"Reversed halo sign on computed tomography: state-of-the-art review","volume":"190","author":"Marchiori","year":"2012","journal-title":"Lung"},{"key":"2019092716314184600_DKW155C88","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2342-10-26","article-title":"Reversed halo sign in pneumocystis pneumonia: a case report","volume":"10","author":"Otara","year":"2010","journal-title":"BMC Med Imaging"},{"key":"2019092716314184600_DKW155C89","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/01.rlu.0000178784.58278.36","article-title":"FDG-PET imaging in Pneumocystis carinii pneumonia","volume":"30","author":"Win","year":"2005","journal-title":"Clin Nucl Med"},{"key":"2019092716314184600_DKW155C90","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/qjmed\/hcq208","article-title":"A diagnostic challenge: PcP in a non-HIV patient","volume":"104","author":"Elias","year":"2011","journal-title":"Q J Med"},{"key":"2019092716314184600_DKW155C91","first-page":"363","article-title":"Immunodeficiency in preclinical smoldering adult T-cell leukemia","volume":"18","author":"Moriyama","year":"1988","journal-title":"Jpn J Clin Oncol"},{"key":"2019092716314184600_DKW155C92","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000334113","article-title":"The increased risk for Pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim\/sulfamethoxazole: a single-center experience","volume":"127","author":"Hardak","year":"2012","journal-title":"Acta Haematol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/71\/9\/2379\/30069086\/dkw155.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T19:59:14Z","timestamp":1692475154000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/71\/9\/2379\/2237794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,12]]},"references-count":92,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,5,12]]},"published-print":{"date-parts":[[2016,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkw155","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,9]]},"published":{"date-parts":[[2016,5,12]]}}}